Mycobacterial surface characters remodeled by growth conditions drive different tumor-infiltrating cells and systemic IFN-γ/IL-17 release in bladder cancer treatment

The mechanism of action of intravesical Mycobacterium bovis BCG immunotherapy treatment for bladder cancer is not completely known, leading to misinterpretation of BCG-unresponsive patients, who have scarce further therapeutic options. BCG is grown under diverse culture conditions worldwide, which c...

Descripción completa

Detalles Bibliográficos
Autores principales: Guallar-Garrido, Sandra, Campo-Pérez, Víctor, Pérez-Trujillo, Míriam, Cabrera, Cecilia, Senserrich, Jordi, Sánchez-Chardi, Alejandro, Rabanal, Rosa Maria, Gómez-Mora, Elisabet, Noguera-Ortega, Estela, Luquin, Marina, Julián, Esther
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959508/
https://www.ncbi.nlm.nih.gov/pubmed/35355681
http://dx.doi.org/10.1080/2162402X.2022.2051845

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959508/
https://www.ncbi.nlm.nih.gov/pubmed/35355681
http://dx.doi.org/10.1080/2162402X.2022.2051845

Ejemplares similares